Sector revisions GSK plc

Equities

Market Closed - London S.E. Other stock markets 16:35:13 11/03/2026 GMT			5-day change	1st Jan Change
2,066.00 ^GBX	+0.10%		-2.64%	+13.24%

09:05pm	GSK plc Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 11:30 AM
05:13pm	FTSE 100 in the Red as US-Iran War Escalates; UK Commits to IEA Oil Stockpile Release	MT

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	GSK PLC							20
	ELI LILLY AND COMPANY							29
	JOHNSON & JOHNSON							24
	ABBVIE INC.							29
	ROCHE HOLDING AG							19
	NOVARTIS AG							21
	ASTRAZENECA PLC							21
	MERCK & CO., INC.							27
	AMGEN INC.							28
	GILEAD SCIENCES, INC.							27
	NOVO NORDISK A/S							21
	PFIZER INC.							26
	BRISTOL-MYERS SQUIBB COMPANY							25
	VERTEX PHARMACEUTICALS INCORPORATED							27
	SANOFI							23
	CHUGAI PHARMACEUTICAL CO., LTD.							15
	TAKEDA PHARMACEUTICAL COMPANY LIMITED							15
	JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD							17
	HALEON PLC							16
	ALNYLAM PHARMACEUTICALS, INC.							25
	Average							23
	Weighted average by Cap.							25